Fate Therapeutics, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↓-27.6% -$122M
$319M
Current Assets↓-28.5% -$83M
$209M
Cash & Equivalents↑+29.3% +$11M
$47M
ST Investments↓-35.4% -$86M
$157M
Receivables↓-74.1% -$3M
$916K
Net PPE↓-11.6% -$7M
$57M
Current Liabilities↓-6.4% -$2M
$36M
Account Payables↓-71.6% -$7M
$3M
Long-Term Debt
—
Stockholders Equity↓-35.0% -$112M
$207M
Retained Earnings↓-9.8% -$136M
$-1.53B
Operating Lease ROU Asset↓-10.5% -$5M
$42M
Operating Lease Liability↑+0.0% +$0
$78M
Gross PP&E↓-6.4% -$6M
$93M
Accumulated Depreciation↑+3.1% +$1M
$36M
Debt Due Y1
—
Debt Due Y2
—
Debt Due Y3
—
Debt Due Y4
—
Debt Due Y5
—
Total Debt Carrying Amount
—
Contract Liability↓-3.1% -$12K
$381K
Contract Liability (Current)↓-3.1% -$12K
$381K
Contract Liability (Noncurrent)
—